H2N2V1, PascalFrancis, Corpus, bibRecord, 000105

The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen

Identifieur interne : 000105 ( PascalFrancis/Corpus ); précédent : 000104; suivant : 000106

The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen

Auteurs : G. N. Milligan ; L. A. Morrison ; J. Gorka ; V. L. Braciale ; T. J. Braciale

Source :

(The) Journal of immunology : (Baltimore, MD. 1950) [ 0022-1767 ] ; 1990.

RBID : Pascal:92-0658912

Descripteurs français

Pascal (Inist)
- Souris, Influenzavirus, Reconnaissance, Système H-2, Système histocompatibilité majeur, Lymphocyte T, Antigène histocompatibilité classe I, Cytotoxicité, Maturation moléculaire, Présentation antigène, Peptide, Produit synthétique.

English descriptors

KwdEn :
- Antigen presentation, Class I histocompatibility antigen, Cytotoxicity, H-2-System, Influenzavirus, Major histocompatibility system, Molecular processing, Mouse, Peptides, Recognition, Synthetic product, T-Lymphocyte.

Abstract

The transmembrane hydrophobic domain of the type A influenza A/JAPAN/305/57 (H2N2) hemagglutinin (HA) contains an immunodominant site encompassing amino acids 523-545 (J523-545) recognized by class I MHC-restricted cytolytic T lymphocytes (CTL). Class I CTL of two fine specificity subsets map to this transmembrane (TM) site. One of these CTL subpopulations is subtype specific

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0022-1767`
A03		`1`		`@0 J. immunol. : (Baltim. MD, 1950)`
A05				`@2 145`
A06				`@2 10`
A08	`01`	`1`	`ENG`	`@1 The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen`
A11	`01`	`1`		`@1 MILLIGAN (G. N.)`
A11	`02`	`1`		`@1 MORRISON (L. A.)`
A11	`03`	`1`		`@1 GORKA (J.)`
A11	`04`	`1`		`@1 BRACIALE (V. L.)`
A11	`05`	`1`		`@1 BRACIALE (T. J.)`
A14	`01`			`@1 Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology @2 Saint Louis MO 63110 @3 USA @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 5 aut.`
A20				`@1 3188-3193`
A21				`@1 1990`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 2039 @5 354000028011250060`
A44				`@0 0000`
A45				`@0 31 ref.`
A47	`01`	`1`		`@0 92-0658912`
A60				`@1 P`
A61				`@0 A`
A64		`1`		`@0 (The) Journal of immunology : (Baltimore, MD. 1950)`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	`@0 The transmembrane hydrophobic domain of the type A influenza A/JAPAN/305/57 (H2N2) hemagglutinin (HA) contains an immunodominant site encompassing amino acids 523-545 (J523-545) recognized by class I MHC-restricted cytolytic T lymphocytes (CTL). Class I CTL of two fine specificity subsets map to this transmembrane (TM) site. One of these CTL subpopulations is subtype specific`
C02	`01`	`X`		`@0 002A06C05B`
C03	`01`	`X`	`FRE`	`@0 Souris`
C03	`01`	`X`	`ENG`	`@0 Mouse`
C03	`01`	`X`	`SPA`	`@0 Ratón`
C03	`02`	`X`	`FRE`	`@0 Influenzavirus @2 NW`
C03	`02`	`X`	`ENG`	`@0 Influenzavirus @2 NW`
C03	`02`	`X`	`SPA`	`@0 Influenzavirus @2 NW`
C03	`03`	`X`	`FRE`	`@0 Reconnaissance`
C03	`03`	`X`	`ENG`	`@0 Recognition`
C03	`03`	`X`	`SPA`	`@0 Reconocimiento`
C03	`04`	`X`	`FRE`	`@0 Système H-2`
C03	`04`	`X`	`ENG`	`@0 H-2-System @6 «H-2»-System`
C03	`04`	`X`	`SPA`	`@0 Sistema H-2`
C03	`05`	`X`	`FRE`	`@0 Système histocompatibilité majeur`
C03	`05`	`X`	`ENG`	`@0 Major histocompatibility system`
C03	`05`	`X`	`SPA`	`@0 Sistema histocompatibilidad mayor`
C03	`06`	`X`	`FRE`	`@0 Lymphocyte T`
C03	`06`	`X`	`ENG`	`@0 T-Lymphocyte @6 «T»-Lymphocyte`
C03	`06`	`X`	`SPA`	`@0 Linfocito T`
C03	`07`	`X`	`FRE`	`@0 Antigène histocompatibilité classe I`
C03	`07`	`X`	`ENG`	`@0 Class I histocompatibility antigen`
C03	`07`	`X`	`SPA`	`@0 Antígeno histocompatibilidad clase I`
C03	`08`	`X`	`FRE`	`@0 Cytotoxicité`
C03	`08`	`X`	`ENG`	`@0 Cytotoxicity`
C03	`08`	`X`	`SPA`	`@0 Citotoxicidad`
C03	`09`	`X`	`FRE`	`@0 Maturation moléculaire`
C03	`09`	`X`	`ENG`	`@0 Molecular processing`
C03	`09`	`X`	`SPA`	`@0 Maduración molecular`
C03	`10`	`X`	`FRE`	`@0 Présentation antigène`
C03	`10`	`X`	`ENG`	`@0 Antigen presentation`
C03	`10`	`X`	`SPA`	`@0 Presentación antígeno`
C03	`11`	`X`	`FRE`	`@0 Peptide`
C03	`11`	`X`	`ENG`	`@0 Peptides`
C03	`11`	`X`	`SPA`	`@0 Péptido`
C03	`12`	`X`	`FRE`	`@0 Produit synthétique`
C03	`12`	`X`	`ENG`	`@0 Synthetic product`
C03	`12`	`X`	`SPA`	`@0 Producto sintético`
C07	`01`	`X`	`FRE`	`@0 Rodentia @2 NS`
C07	`01`	`X`	`ENG`	`@0 Rodentia @2 NS`
C07	`01`	`X`	`SPA`	`@0 Rodentia @2 NS`
C07	`02`	`X`	`FRE`	`@0 Mammalia @2 NS`
C07	`02`	`X`	`ENG`	`@0 Mammalia @2 NS`
C07	`02`	`X`	`SPA`	`@0 Mammalia @2 NS`
C07	`03`	`X`	`FRE`	`@0 Vertebrata @2 NS`
C07	`03`	`X`	`ENG`	`@0 Vertebrata @2 NS`
C07	`03`	`X`	`SPA`	`@0 Vertebrata @2 NS`
C07	`04`	`X`	`FRE`	`@0 Orthomyxoviridae @2 NW`
C07	`04`	`X`	`ENG`	`@0 Orthomyxoviridae @2 NW`
C07	`04`	`X`	`SPA`	`@0 Orthomyxoviridae @2 NW`
C07	`05`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`05`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`05`	`X`	`SPA`	`@0 Virus @2 NW`
N21				`@1 352`

Format Inist (serveur)

NO :	PASCAL 92-0658912 INIST
ET :	The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen
AU :	MILLIGAN (G. N.); MORRISON (L. A.); GORKA (J.); BRACIALE (V. L.); BRACIALE (T. J.)
AF :	Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology/Saint Louis MO 63110/Etats-Unis (1 aut., 2 aut., 4 aut., 5 aut.)
DT :	Publication en série; Niveau analytique
SO :	(The) Journal of immunology : (Baltimore, MD. 1950); ISSN 0022-1767; Etats-Unis; Da. 1990; Vol. 145; No. 10; Pp. 3188-3193; Bibl. 31 ref.
LA :	Anglais
EA :	The transmembrane hydrophobic domain of the type A influenza A/JAPAN/305/57 (H2N2) hemagglutinin (HA) contains an immunodominant site encompassing amino acids 523-545 (J523-545) recognized by class I MHC-restricted cytolytic T lymphocytes (CTL). Class I CTL of two fine specificity subsets map to this transmembrane (TM) site. One of these CTL subpopulations is subtype specific
CC :	002A06C05B
FD :	Souris; Influenzavirus; Reconnaissance; Système H-2; Système histocompatibilité majeur; Lymphocyte T; Antigène histocompatibilité classe I; Cytotoxicité; Maturation moléculaire; Présentation antigène; Peptide; Produit synthétique
FG :	Rodentia; Mammalia; Vertebrata; Orthomyxoviridae; Virus
ED :	Mouse; Influenzavirus; Recognition; H-2-System; Major histocompatibility system; T-Lymphocyte; Class I histocompatibility antigen; Cytotoxicity; Molecular processing; Antigen presentation; Peptides; Synthetic product
EG :	Rodentia; Mammalia; Vertebrata; Orthomyxoviridae; Virus
SD :	Ratón; Influenzavirus; Reconocimiento; Sistema H-2; Sistema histocompatibilidad mayor; Linfocito T; Antígeno histocompatibilidad clase I; Citotoxicidad; Maduración molecular; Presentación antígeno; Péptido; Producto sintético
LO :	INIST-2039.354000028011250060
ID :	92-0658912

Links to Exploration step

Pascal:92-0658912

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen</title>
<author><name sortKey="Milligan, G N" sort="Milligan, G N" uniqKey="Milligan G" first="G. N." last="Milligan">G. N. Milligan</name>
<affiliation><inist:fA14 i1="01"><s1>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology</s1>
<s2>Saint Louis MO 63110</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Morrison, L A" sort="Morrison, L A" uniqKey="Morrison L" first="L. A." last="Morrison">L. A. Morrison</name>
<affiliation><inist:fA14 i1="01"><s1>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology</s1>
<s2>Saint Louis MO 63110</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gorka, J" sort="Gorka, J" uniqKey="Gorka J" first="J." last="Gorka">J. Gorka</name>
</author>
<author><name sortKey="Braciale, V L" sort="Braciale, V L" uniqKey="Braciale V" first="V. L." last="Braciale">V. L. Braciale</name>
<affiliation><inist:fA14 i1="01"><s1>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology</s1>
<s2>Saint Louis MO 63110</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Braciale, T J" sort="Braciale, T J" uniqKey="Braciale T" first="T. J." last="Braciale">T. J. Braciale</name>
<affiliation><inist:fA14 i1="01"><s1>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology</s1>
<s2>Saint Louis MO 63110</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">92-0658912</idno>
<date when="1990">1990</date>
<idno type="stanalyst">PASCAL 92-0658912 INIST</idno>
<idno type="RBID">Pascal:92-0658912</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000105</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen</title>
<author><name sortKey="Milligan, G N" sort="Milligan, G N" uniqKey="Milligan G" first="G. N." last="Milligan">G. N. Milligan</name>
<affiliation><inist:fA14 i1="01"><s1>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology</s1>
<s2>Saint Louis MO 63110</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Morrison, L A" sort="Morrison, L A" uniqKey="Morrison L" first="L. A." last="Morrison">L. A. Morrison</name>
<affiliation><inist:fA14 i1="01"><s1>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology</s1>
<s2>Saint Louis MO 63110</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gorka, J" sort="Gorka, J" uniqKey="Gorka J" first="J." last="Gorka">J. Gorka</name>
</author>
<author><name sortKey="Braciale, V L" sort="Braciale, V L" uniqKey="Braciale V" first="V. L." last="Braciale">V. L. Braciale</name>
<affiliation><inist:fA14 i1="01"><s1>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology</s1>
<s2>Saint Louis MO 63110</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Braciale, T J" sort="Braciale, T J" uniqKey="Braciale T" first="T. J." last="Braciale">T. J. Braciale</name>
<affiliation><inist:fA14 i1="01"><s1>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology</s1>
<s2>Saint Louis MO 63110</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">(The) Journal of immunology : (Baltimore, MD. 1950)</title>
<title level="j" type="abbreviated">J. immunol. : (Baltim. MD, 1950)</title>
<idno type="ISSN">0022-1767</idno>
<imprint><date when="1990">1990</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">(The) Journal of immunology : (Baltimore, MD. 1950)</title>
<title level="j" type="abbreviated">J. immunol. : (Baltim. MD, 1950)</title>
<idno type="ISSN">0022-1767</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antigen presentation</term>
<term>Class I histocompatibility antigen</term>
<term>Cytotoxicity</term>
<term>H-2-System</term>
<term>Influenzavirus</term>
<term>Major histocompatibility system</term>
<term>Molecular processing</term>
<term>Mouse</term>
<term>Peptides</term>
<term>Recognition</term>
<term>Synthetic product</term>
<term>T-Lymphocyte</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Souris</term>
<term>Influenzavirus</term>
<term>Reconnaissance</term>
<term>Système H-2</term>
<term>Système histocompatibilité majeur</term>
<term>Lymphocyte T</term>
<term>Antigène histocompatibilité classe I</term>
<term>Cytotoxicité</term>
<term>Maturation moléculaire</term>
<term>Présentation antigène</term>
<term>Peptide</term>
<term>Produit synthétique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The transmembrane hydrophobic domain of the type A influenza A/JAPAN/305/57 (H2N2) hemagglutinin (HA) contains an immunodominant site encompassing amino acids 523-545 (J523-545) recognized by class I MHC-restricted cytolytic T lymphocytes (CTL). Class I CTL of two fine specificity subsets map to this transmembrane (TM) site. One of these CTL subpopulations is subtype specific</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0022-1767</s0>
</fA01>
<fA03 i2="1"><s0>J. immunol. : (Baltim. MD, 1950)</s0>
</fA03>
<fA05><s2>145</s2>
</fA05>
<fA06><s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MILLIGAN (G. N.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MORRISON (L. A.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>GORKA (J.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>BRACIALE (V. L.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BRACIALE (T. J.)</s1>
</fA11>
<fA14 i1="01"><s1>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology</s1>
<s2>Saint Louis MO 63110</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>3188-3193</s1>
</fA20>
<fA21><s1>1990</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>2039</s2>
<s5>354000028011250060</s5>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>31 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>92-0658912</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>(The) Journal of immunology : (Baltimore, MD. 1950)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The transmembrane hydrophobic domain of the type A influenza A/JAPAN/305/57 (H2N2) hemagglutinin (HA) contains an immunodominant site encompassing amino acids 523-545 (J523-545) recognized by class I MHC-restricted cytolytic T lymphocytes (CTL). Class I CTL of two fine specificity subsets map to this transmembrane (TM) site. One of these CTL subpopulations is subtype specific</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A06C05B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Souris</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Mouse</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Ratón</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Influenzavirus</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Influenzavirus</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Influenzavirus</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Reconnaissance</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Recognition</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Reconocimiento</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Système H-2</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>H-2-System</s0>
<s6>«H-2»-System</s6>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Sistema H-2</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Système histocompatibilité majeur</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Major histocompatibility system</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Sistema histocompatibilidad mayor</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Lymphocyte T</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>T-Lymphocyte</s0>
<s6>«T»-Lymphocyte</s6>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Linfocito T</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Antigène histocompatibilité classe I</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Class I histocompatibility antigen</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Antígeno histocompatibilidad clase I</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Cytotoxicité</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Cytotoxicity</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Citotoxicidad</s0>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Maturation moléculaire</s0>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Molecular processing</s0>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Maduración molecular</s0>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Présentation antigène</s0>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Antigen presentation</s0>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Presentación antígeno</s0>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Peptide</s0>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Peptides</s0>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Péptido</s0>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Produit synthétique</s0>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Synthetic product</s0>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Producto sintético</s0>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fN21><s1>352</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 92-0658912 INIST</NO>
<ET>The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen</ET>
<AU>MILLIGAN (G. N.); MORRISON (L. A.); GORKA (J.); BRACIALE (V. L.); BRACIALE (T. J.)</AU>
<AF>Washington univ. school medicine, Howard-Hughes medical inst., dep. pathology/Saint Louis MO 63110/Etats-Unis (1 aut., 2 aut., 4 aut., 5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>(The) Journal of immunology : (Baltimore, MD. 1950); ISSN 0022-1767; Etats-Unis; Da. 1990; Vol. 145; No. 10; Pp. 3188-3193; Bibl. 31 ref.</SO>
<LA>Anglais</LA>
<EA>The transmembrane hydrophobic domain of the type A influenza A/JAPAN/305/57 (H2N2) hemagglutinin (HA) contains an immunodominant site encompassing amino acids 523-545 (J523-545) recognized by class I MHC-restricted cytolytic T lymphocytes (CTL). Class I CTL of two fine specificity subsets map to this transmembrane (TM) site. One of these CTL subpopulations is subtype specific</EA>
<CC>002A06C05B</CC>
<FD>Souris; Influenzavirus; Reconnaissance; Système H-2; Système histocompatibilité majeur; Lymphocyte T; Antigène histocompatibilité classe I; Cytotoxicité; Maturation moléculaire; Présentation antigène; Peptide; Produit synthétique</FD>
<FG>Rodentia; Mammalia; Vertebrata; Orthomyxoviridae; Virus</FG>
<ED>Mouse; Influenzavirus; Recognition; H-2-System; Major histocompatibility system; T-Lymphocyte; Class I histocompatibility antigen; Cytotoxicity; Molecular processing; Antigen presentation; Peptides; Synthetic product</ED>
<EG>Rodentia; Mammalia; Vertebrata; Orthomyxoviridae; Virus</EG>
<SD>Ratón; Influenzavirus; Reconocimiento; Sistema H-2; Sistema histocompatibilidad mayor; Linfocito T; Antígeno histocompatibilidad clase I; Citotoxicidad; Maduración molecular; Presentación antígeno; Péptido; Producto sintético</SD>
<LO>INIST-2039.354000028011250060</LO>
<ID>92-0658912</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000105 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000105 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:92-0658912
   |texte=   The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021

	Serveur d'exploration H2N2
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration H2N2

The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen

The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri